347
Views
1
CrossRef citations to date
0
Altmetric
Research Papers

Prescription opioid misuse among Black and White older adults

&
Pages 25-32 | Received 12 Jan 2021, Accepted 09 Mar 2021, Published online: 30 Mar 2021

References

  • Banks DE, Zapolski TC. 2018. The crossover effect: a review of racial/ethnic variations in risk for substance use and substance use disorder across development. Curr Addict Rep. 5(3):386–395.
  • Beaudoin FL, Straube S, Lopez J, Mello MJ, Baird J. 2014. Prescription opioid misuse among ED patients discharged with opioids. Am J Emerg Med. 32(6):580–585.
  • Becker WC, Fiellin DA, Gallagher RM, Barth KS, Ross JT, Oslin DW. 2009. The association between chronic pain and prescription drug abuse in Veterans. Pain Med. 10(3):531–536.
  • Blanco C, Alderson D, Ogburn E, Grant BF, Nunes EV, Hatzenbuehler ML, Hasin DS. 2007. Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991–1992 and 2001–2002. Drug Alcohol Depend. 90(2–3):252–260.
  • Bohnert ASB, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, Blow FC. 2011. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 305(13):1315–1321.
  • Brennan PL, Nichol AC, Moos RH. 2003. Older and younger patients with substance use disorders: outpatient mental health service use and functioning over a 12-month interval. Psychol Addict Behav. 17(1):42–48.
  • Broman CL, Neighbors HW, Delva J, Torres M, Jackson JS. 2008. Prevalence of substance use disorders among African Americans and Caribbean Blacks in the National Survey of American Life. Am J Public Health. 98(6):1107–1114.
  • Carise D, Dugosh KL, McLellan AT, Camilleri A, Woody GE, Lynch KG. 2007. Prescription OxyContin abuse among patients entering addiction treatment. Am J Psychiatry. 164(11):1750–1756.
  • [CBHSQ] Center for Behavioral Health Statistics and Quality. 2017a. 2016 National survey on drug use and health: detailed tables. Rockville (MD): Substance Abuse and Mental Health Services. Administration.
  • Center for Behavioral Health Statistics and Quality. 2017b. 2017 National survey on drug use and health public use file codebook. Rockville (MD): Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/…/DAWN127/DAWN127/sr127-DAWN-highlights.pdf.
  • Chan KTK, Zhou S, Marsack-Topolewski C. 2020. Race differences in opioid misuse and adolescent suicidality. Child and Adolesc Social Work J. DOI:https://doi.org/10.1007/s10560-020-00721-0.
  • Chau DL, Walker V, Pai L, Cho LM. 2008. Opiates and elderly: use and side effects. Clin Interv Aging. 3(2):273–278.
  • Chou R, Deyo R, Devine B, Hansen R, Sullivan S, Jarvik JG, Blazina I, Dana T, Bougatsos C, Turner J. 2014. The effectiveness and risks of long-term opioid treatment of chronic pain. Evidence report/technology assessment no. 218 (prepared by the Pacific Northwest Evidence-based Practice Center under contract no. 290-2012-00014-I). AHRQ publication no. 14-E005-EF. Rockville (MD): Agency for Healthcare Research and Quality.
  • Dowling K, Storr CL, Chilcoat HD. 2006. Potential influences on initiation and persistence of extramedical prescription pain reliever use in the US population. Clin J Pain. 22(9):776–783.
  • Elmståhl S, Linder H. 2013. Polypharmacy and inappropriate drug use among older people–A systematic review. Healthy Aging Clin Care Elder. 5:1.
  • Ford JA, Rigg KK. 2015. Racial/ethnic differences in factors that place adolescents at risk for prescription opioid misuse. Prev Sci. 16(5):633–641.
  • Fuller-Thomson E, Nuru-Jeter A, Minkler M, Guralnik JM. 2009. Black-White disparities in disability among older Americans: further untangling the role of race and socioeconomic status. J Aging Health. 21(5):677–698.
  • Gossop M, Moos R. 2008. Substance misuse among older adults: a neglected but treatable problem. Addiction. 103(3):347–348.
  • Goyal MK, Kuppermann N, Cleary SD, Teach SJ, Chamberlain JM. 2015. Racial disparities in pain management of children with appendicitis in emergency departments. JAMA Pediatr. 169(11):996–1002.
  • Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. 2017. Prescription opioid use, misuse, and use disorders in US adults: 2015 National Survey on Drug Use and Health. Ann Intern Med. 167(5):293–301.
  • Han BH, Sherman SE, Palamar JJ. 2019. Prescription opioid misuse among middle-aged and older adults in the United States, 2015-2016. Prev Med. 121:94–98.
  • Hanlon JT, Guay DRP, Ives TJ. 2005. Oral analgesics: efficacy, mechanism of action, pharmacokinetics, adverse effects, drug interactions, and practical recommendations for use in older adults. Prog Pain Res Manag. 35:205–222.
  • Hamilton TG. 2019. Immigration and the remaking of Black America. New York (NY): Russell Sage Foundation.
  • Hansen H, Netherland J. 2016. Is the opioid epidemic a white problem? Am J Public Health. 106(12):2127–2129.
  • Harrell ZA, Broman CL. 2009. Racial/ethnic differences in correlates of prescription drug misuse among young adults. Drug Alcohol Depend. 104(3):268–271.
  • Harris KM, Edlund MJ. 2005. Self‐medication of mental health problems: new evidence from a national survey. Health Serv Res. 40(1):117–134.
  • Havens JR, Oser CB, Leukefeld CG, Webster JM, Martin SS, O'Connell DJ, Surratt HL, Inciardi JA. 2007. Differences in prevalence of prescription opiate misuse among rural and urban probationers. Am J Drug Alcohol Abuse. 33(2):309–317.
  • Havens JR, Young AM, Havens CE. 2011. Nonmedical prescription drug use in a nationally representative sample of adolescents: evidence of greater use among rural adolescents. Arch Pediatr Adolesc Med. 165(3):250–255.
  • Hser Y-I, Hamilton A, Niv N. 2009. Understanding drug use over the life course: past, present, and future. J Drug Issues. 39(1):231–236.
  • Hudgins JD, Porter JJ, Monuteaux MC, Bourgeois FT. 2019. Prescription opioid use and misuse among adolescents and young adults in the United States: a national survey study. PLoS Med. 16(11):e1002922.
  • Kalapatapu RK, Sullivan MA. 2010. Prescription use disorders in older adults. Am J Addict. 19(6):515–522.
  • Katz C, El-Gabalawy R, Keyes KM, Martins SS, Sareen J. 2013. Risk factors for incident nonmedical prescription opioid use and abuse and dependence: results from a longitudinal nationally representative sample. Drug Alcohol Depend. 132(1–2):107–113.
  • Lembke A, Chen JH. 2016. Use of opioid agonist therapy for Medicare patients in 2013. JAMA Psychiatry. 73(9):990–992.
  • Linnebur SA, O’Connell MB, Wessell AM, McCord AD, Kennedy DH, DeMaagd G, Dent LA, Splinter MY, Biery JC, Chang F. 2005. Pharmacy practice, research, education, and advocacy for older adults American College of Pharmacy. Pharmacotherapy. 25(10):1396–1430.
  • Manchikanti L, Giordano J, Boswell MV, Fellows B, Manchukonda R, Pampati BV. 2007. Psychological factors as predictors of opioid abuse and illicit drug use in chronic pain patients. J Opioid Manag. 3(2):89–100.
  • McCabe SE, Cranford JA, West BT. 2008. Trends in prescription drug abuse and dependence, co-occurrence with other substance use disorders, and treatment utilization: results from two national surveys. Addict Behav. 33(10):1297–1305.
  • McCabe SE, Teter CJ, Boyd CJ, Knight JR, Wechsler H. 2005. Nonmedical use of prescription opioids among US college students: prevalence and correlates from a national survey. Addict Behav. 30(4):789–805.
  • Monnat SM, Rigg KK. 2016. Examining rural/urban differences in prescription opioid misuse among US adolescents. J Rural Health. 32(2):204–218.
  • Monnat SM, Rigg KK. 2018. The opioid crisis in rural and small town America. University of New Hampshire, Carsey School of Public Policy (Issue Brief #135).
  • Mowbray O, Quinn A. 2015. Prescription pain reliever misuse prevalence, correlates, and origin of possession throughout the life course. Addict Behav. 50:22–27.
  • Nasim A, Fernander A, Townsend TG, Corona R, Belgrave FZ. 2011. Cultural protective factors for community risks and substance use among rural African American adolescents. J Ethn Subst Abuse. 10(4):316–336.
  • Nicholson HL, Ford JA. 2018. Correlates of prescription opioid misuse among Black adults: findings from the 2015 National Survey on Drug Use and Health. Drug Alcohol Depend. 186:264–267.
  • Nicholson HL, Vincent J. 2019. Gender differences in prescription opioid misuse among US Black adults. Subst Use Misuse. 54(4):639–650.
  • Osborne V, Serdarevic M, Crooke H, Striley C, Cottler LB. 2017. Non-medical opioid use in youth: gender differences in risk factors and prevalence. Addict Behav. 72:114–119.
  • Peteet BJ. 2019. Psychosocial risks of prescription drug misuse among US racial/ethnic minorities: a systematic review. J Ethn Subst Abuse. 18(3):476–508.
  • Pouget ER, Fong C, Rosenblum A. 2018. Racial/ethnic differences in prevalence trends for heroin use and non-medical use of prescription opioids among entrants to opioid treatment programs, 2005-2016. Subst Use Misuse. 53(2):290–300.
  • Renthal W. 2016. Seeking balance between pain relief and safety: CDC issues new opioid-prescribing guidelines. JAMA Neurol. 73(5):513–514.
  • Rigg KK. 2017. Motivations for using MDMA (ecstasy/molly) among African Americans: implications for prevention and harm-reduction programs. J Psychoactive Drugs. 49(3):192–200.
  • Rigg KK, DeCamp W. 2014. Explaining prescription opioid misuse among veterans: a theory-based analysis using structural equation modeling. Mil Behav Health. 2(2):210–216.
  • Rigg KK, Ibañez GE. 2010. Motivations for non-medical prescription drug use: a mixed methods analysis. J Subst Abuse Treat. 39(3):236–247.
  • Rigg KK, McLean K, Monnat SM, Sterner GE, III, Verdery AM. 2018. Opioid misuse initiation: implications for intervention. J Addict Dis. 37(3–4):111–122.
  • Rigg KK, Monnat SM. 2015. Urban vs. rural differences in prescription opioid misuse among adults in the United States: informing region specific drug policies and interventions. Int J Drug Policy. 26(5):484–491.
  • Rigg KK, Monnat SM, Chavez MN. 2018. Opioid-related mortality in rural America: geographic heterogeneity and intervention strategies. Int J Drug Policy. 57:119–129.
  • Rigg KK, Nicholson HL. 2019. Prescription opioid misuse among African-American adults: a rural-urban comparison of prevalence and risk. Drug Alcohol Depend. 197:191–196.
  • Rigg KK, Sharp A. 2018. Nonmedical prescription drug use among African Americans who use MDMA (ecstasy/molly): implications for risk reduction. Addict Behav. 79:159–165.
  • Rosenblum A, Parrino M, Schnoll SH, Fong C, Maxwell C, Cleland CM, Magura S, Haddox JD. 2007. Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug Alcohol Depend. 90(1):64–71.
  • Schepis TS, Ford JA, Wastila L, McCabe SE. 2020. Opioid-involved prescription drug misuse and poly-prescription drug misuse in US older adults. Aging Ment Health. 1–9.
  • Schepis TS, McCabe SE. 2016. Trends in older adult nonmedical prescription drug use prevalence: results from the 2002–2003 and 2012–2013 National Survey on Drug Use and Health. Addict Behav. 60:219–222.
  • Shuey KM, Willson AE. 2008. Cumulative disadvantage and Black-White disparities in life-course health trajectories. Res Aging. 30(2):200–225.
  • Singhal A, Tien YY, Hsia RY. 2016. Racial-ethnic disparities in opioid prescriptions at emergency department visits for conditions commonly associated with prescription drug abuse. PLoS One. 11(8):e0159224.
  • Skarupski KA, De Leon CFM, Bienias JL, Scherr PA, Zack MM, Moriarty DG, Evans DA. 2007. Black–white differences in health-related quality of life among older adults. Qual Life Res. 16(2):287–296.
  • Watkins WC, Ford JA. 2011. Prescription drug misuse among Asian-American adults: results from a national survey. Subst Use Misuse. 46(13):1700–1708.
  • West NA, Severtson SG, Green JL, Dart RC. 2015. Trends in abuse and misuse of prescription opioids among older adults. Drug Alcohol Depend. 149:117–121.
  • Williams DR, Jackson PB. 2005. Social sources of racial disparities in health. Health Aff (Millwood)). 24(2):325–334.
  • Zapolski TC, Pedersen SL, McCarthy DM, Smith GT. 2014. Less drinking, yet more problems: understanding African American drinking and related problems. Psychol Bull. 140(1):188–223.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.